2018
DOI: 10.1016/j.plefa.2018.07.014
|View full text |Cite
|
Sign up to set email alerts
|

Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding

Abstract: HighlightsA molecular mechanism underlying the albumin-cobalt binding assay.Free fatty acid binding interferes with Co(II) binding to albumin.Ischemia-modified albumin corresponds to albumin with increased FFA bound.Increased FFA levels are sufficient to explain high ACB readings.Clinical data are consistent with FFA as the trigger for high ACB/high IMA levels.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
36
0
5

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 46 publications
(43 citation statements)
references
References 149 publications
(262 reference statements)
2
36
0
5
Order By: Relevance
“…The concentrations of plasma FFAs have been observed to sharply increase in cases of myocardial infarction [ 129 , 130 ], presumably due to reduced consumption by the heart muscle. This will lead to high FFA-loading of serum albumin, and we have proposed [ 33 , 55 , 131 ] that this state of albumin corresponds to the clinically approved biomarker “ischemia-modified albumin” (IMA) [ [132] , [133] , [134] , [135] ]. IMA is quantified by the albumin‑cobalt-binding (ACB) assay, by indirectly measuring the reduced cobalt-binding ability of HSA.…”
Section: Cardiovascular Disease and Haemostasismentioning
confidence: 99%
See 2 more Smart Citations
“…The concentrations of plasma FFAs have been observed to sharply increase in cases of myocardial infarction [ 129 , 130 ], presumably due to reduced consumption by the heart muscle. This will lead to high FFA-loading of serum albumin, and we have proposed [ 33 , 55 , 131 ] that this state of albumin corresponds to the clinically approved biomarker “ischemia-modified albumin” (IMA) [ [132] , [133] , [134] , [135] ]. IMA is quantified by the albumin‑cobalt-binding (ACB) assay, by indirectly measuring the reduced cobalt-binding ability of HSA.…”
Section: Cardiovascular Disease and Haemostasismentioning
confidence: 99%
“…The identification of IMA as HSA with a high FFA load explains essentially all clinical observations, including the lack of specificity: Elevated FFA levels are a hallmark of numerous other conditions and diseases including cancer [ 139 ], diabetes [ 78 ], and stroke [ 140 ]. Invariably, positive ACB assays have been found in these and many other conditions [ 73 , 131 ]. We also note that our hypothesis would predict depressed serum zinc levels for all conditions that elicit positive ACB assays, and this appears to be the case [ 131 ]; some of these conditions are listed in Table 1 .…”
Section: Cardiovascular Disease and Haemostasismentioning
confidence: 99%
See 1 more Smart Citation
“…İskemi modifiye albümin (IMA), iskemik koşullarda oksijen radikallerinin albüminin N-terminaline hasar vermesiyle oluşan bir varyant proteindir. Klinik çalışmalarda, genellikle iskemik ataktan 6-12 saat içinde yükselmeye başlar ve 24 saat sonra da normal değerlerine düşmeye başlar [28][29][30] [34][35][36][37]. Bu çalışmada, oksidan ve antioksidan sistemin göstergesi olduğu iddia edilen bu parametreler, iki deneysel travma modelinde karşılaştırmalı olarak incelenmiştir.…”
Section: Discussionunclassified
“…178 Thus, FFA binding alters conformational changes and inhibits the metal ion binding to albumin. 179,180 Chronic diseases associated with ''glycated/ oxidized'' albumin, oxidative stress generates ''irreversible'' oxidation-modified albumin secondary to oxidation adducts on albumin. 176 Henceforth, the use of both standard ACB assay and ELISA tests for determining IMA levels is ideal.…”
Section: St2mentioning
confidence: 99%